FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Nearly One-in-Six Americans Have Acted on AI Medical Advice Without Speaking to Human, Poll Shows

ICYMI: Judge Shuts Down Democrats’ Attempt to Rush in Late Votes After Candidates Drop Out

Top Dem operative brushes off latest scandal plaguing Maine Senate candidate as ‘salacious gossip’

Gun rights gets ‘greatest restoration’ in 100 years with latest Trump DOJ move, lawmaker hails

Democrats realize they love Haley Stevens, just a little too late

Veteran pediatrician hails Medicaid shift ending youth sex-change treatments: ‘This is not denial of care’

Legal expert calls for Smithsonian leadership overhaul over ‘self-loathing’ portrayal of history: ‘It’s bile’

Man charged with assault, hate crimes after allegedly disrupting Shabbat services at NYC synagogue

Shake Shack worker allegedly calls out before robbing own restaurant, returns in uniform 2 days later

California Man Receives Postcard Sent by His Late Parents 26 Years Ago

DFW Airport scraps controversial Islamic foot-washing station plan as Texas Gov Abbott takes aim

California teen faces prison after viral video shows him squaring up, repeatedly kicking sea lion in the face

Delta flight diverted twice after lavatory leak floods cabin, leaves passengers stranded for hours

Reagan National Airport makes drastic change following deadly 2025 midair collision

Watch: Little League Coach Declares, ‘Jesus Is Still Lord’ Live on ESPN

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”